Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biomarkers 2014

Declan Jones's Biography



Declan Jones, Neuroscience Therapeutic Area Lead, J&J London Innovation Centre

Declan N.C. Jones, PhD joined the newly established J&J London Innovation Centre in June 2013 as VP and Neuroscience Lead. The London Innovation Centre (http://www.jnjinnovation.com/) will build relationships with the academic institutions, biotech organizations and venture capital firms in the UK and will be a base for outreach throughout Europe. Declan is particular focused on identifying opportunities for the treatment for Alzheimer’s disease and mood disorders, including diagnostics and biomarkers. Prior to this role, Declan was Head of Research for GlaxoSmithKline’s Centre of Excellence for External Drug Discovery (CEEDD) after spending fourteen years in roles with increasing responsibility in CNS drug discovery within GlaxoSmithKline, finishing as Director of In Vivo Neurobiology and also Disease Area Strategy Leader for Schizophrenia and Bipolar Disorders.

Declan Jones Image

Different "Business Models" in CNS Drug Discovery/Development

Wednesday, 9 July 2014 at 14:15

Add to Calendar ▼2014-07-09 14:15:002014-07-09 15:15:00Europe/LondonDifferent "Business Models" in CNS Drug Discovery/Development Biomarkers 2014 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com

This presentation will describe J&J's approach to partnership within the neuroscience area, with specific examples in CNS biomarkers. This is exemplified by the establishment of our Innovation Centres in London, Boston, San Francisco, and Shanghai.


Add to Calendar ▼2014-07-08 00:00:002014-07-09 00:00:00Europe/LondonBiomarkers 2014Biomarkers 2014 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com